Maytansinoid compound
US4362663A · kind A · utility
291Cited by
2References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 1980 |
| Grant date | Dec 7, 1982 |
| Priority date | — |
| Expiry date | Sep 17, 2000 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/872
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Antibiotic C-15003 PND of the formula: ##STR1## wherein R is H or alkanoyl containing not more than 5 carbon atoms is produced by contacting a maytansinoid compound with a culture broth, inclusive of a processed matter derived therefrom, of a microorganism belonging to one of the genera Streptomyces and Chainia which is able to transform said maytansinoid compound into Antibiotic C-15003 PND. Antibiotic C-15003 PND is useful as antitumor, antifungal or antiprotozoal agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.